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Abstract
Hereditary degenerative brain disorders (HDBDs) are a unique class of genetic
conditions that result in progressive loss of function within the nervous system, many of
which present during adulthood. Given this, the diagnosis of a HDBD can be daunting for
both the patient and the genetic counselor assisting in medical care. The purpose of this
study was to find themes among genetic counselors who see this patient population and
help provide a framework to counselors entering this field by recognizing verified
methods of HDBD counseling. Sixteen genetic counselors who routinely see patients atrisk for HDBDs were interviewed concerning how they prepared for and engaged with
their patients, how they handled the complex emotions frequently associated with
presymptomatic HDBD counseling, and how they perceived the stress levels and coping
mechanisms of their patients. The results of this study showed that genetic counselors
who see patients at-risk for HDBDs utilize agendas and/or protocols in preparing for and
directing sessions. Additionally, these genetic counselors perceive their HDBD patients
as capable of coping with their own presymptomatic testing results. There was not
enough evidence from this study to determine if genetic counselors who see patients at
risk for HDBDs are at any greater risk for compassion fatigue than other genetic
counselors. Overall, the genetic counselors who see patients at risk for HDBDs are more
similar to than different from genetic counselors who do not see this patient population.
Given that a significant number of people are living at risk for HDBDs, experiences in
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case observation and counseling alongside expert HDBD counselors could benefit genetic
counselors and the patients they serve.
Keywords: Hereditary degenerative brain disorders, Huntington disease,
Alzheimer disease, adult-onset neurodegenerative disorders, presymptomatic genetic
testing, genetic counseling
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Chapter 1: Background
Hereditary degenerative brain disorders (HDBDs) are a unique class of genetic conditions
that result in progressive loss of function within the nervous system. In many of these
disorders, such as Alzheimer disease (AD), amyotrophic lateral sclerosis, or
frontotemporal dementia, the affected individuals experience physical and/or mental
regression as the brain degenerates during adulthood. Given this, the diagnosis of a
HDBD can be daunting for both the patient and the genetic counselor assisting in medical
care. Huntington disease (HD) is a HDBD and an ideal model genetic disease for this
study as the guidelines for the molecular genetics predictive test in Huntington’s disease
(IHA & WFN, 1994) provide a widely accepted model for presymptomatic testing for
other adult-onset disorders (Goldman et al., 2011; Guimarães, Sequeiros, Skirton, &
Paneque, 2013).
1.1 Huntington Disease
Huntington disease was first known as Huntington’s disease; that is, it was named
after George Huntington who identified the symptoms of HD as well as documented the
disease as being heritable (Shoulson & Young, 2011). Currently, HD affects less than or
equal to 1 in 10,000 people (Ha & Fung, 2012; Shoulson & Young, 2011). Though HD
usually affects adults, symptoms can appear as early as infancy depending on the number
of trinucleotide Cytosine-Adenine-Guanine (CAG) repeats (Ha & Fung, 2012; Koutsis,
Karadima, Kladi, & Panas, 2013).

1

The natural history and progression of HD has been associated with the
trinucleotide repeat number of the Huntingtin gene (HTT) (Ha & Fung, 2012; Semaka,
Balneaves, & Hayden, 2012; Shoulson & Young, 2011). A higher repeat number can
often mean an earlier onset of symptoms (Ha & Fung, 2012; Semaka et al., 2012;
Shoulson & Young, 2011). Even so, no accurate estimate for age of onset can currently
be made by counting the repeat number (Ha & Fung, 2012; Semaka et al., 2012). It is
suspected that other factors, whether genetic or environmental, may contribute to the age
of onset for HD (Semaka et al., 2012; Shoulson & Young, 2011).
Ha and Fung (2012) have reported that signs of HD can be present during the
presymptomatic, or prodromal, stage of this disease years before a clinical diagnosis is
confirmed. MRI scans have shown in some studies that presymptomatic individuals have
brain atrophy before the diagnosis and this progresses throughout the course of HD. Tests
measuring skills in visuomotor performance, emotion recognition tasks, and working
memory can separate presymptomatic HD patients who are closer to their expected age of
onset from control groups. Studies have shown dysfunction in self-paced timing tasks,
occulomotor function, tongue protrusion forces, and finger tapping tasks among
prodromal individuals.
The age of onset of HD can be quite variable among individuals and is frequently
family specific, with the mean age of onset about at 40 years (Ha & Fung, 2012;
Heemskerk & Roos, 2012; Myers, Madden, Teague, & Falek, 1982; Shoulson & Young,
2011). Onset of clinical symptoms is different for each individual with some having
primarily chorea with little cognitive dysfunction as measured by cognitive testing and
other individuals having cognitive dysfunction with little motor involvement, yet
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symptoms progressively become worse for all (R. Abramson & E. Frank, personal
communication, 04/06/2013). Chorea may start in the distal limbs and in the facial
muscles (Ha & Fung, 2012). Over time, chorea may decrease, and increased rigidity and
dystonia become more pronounced (Ha & Fung, 2012). Throughout the course of the
disease, features such as bradykinesia, ideomotor apraxia, motor impersistence,
dysarthria, and dysphasia may be present (Ha & Fung, 2012; Heemskerk & Roos, 2012).
Progressive loss of executive functioning, attention, visuospatial and construction skills
can occur from dementia (Ha & Fung, 2012). Behavioral changes such as irritability,
aggression, psychosis, and sometimes suicidal ideation may be present at any time during
the disease (Ha & Fung, 2012).
HD patients often need extensive help with activities of daily living and medical
aid at the end-stages of the disease. The leading cause of death for persons with HD is
aspiration pneumonia, secondary to dysphagia (Heemskerk & Roos, 2012). Loss of motor
control and balance can contribute to frequent falls, some of which have led to early
demise (Ha & Fung, 2012). Death tends to occur between the first and second decade
after the onset of HD (Heemskerk & Roos, 2012; Keenan, Simpson, Miedzybrodzka,
Alexander, & Semper, 2013; Semaka et al., 2012).
A variety of non-curative treatments have been developed for symptoms of HD
(Nance, 2012). These include medications for symptoms such as chorea, psychosis, and
aggressive behavior; management strategies such as speech, augmentative
communication, physical, and occupational therapies (Ferm, Sahlin, Sundin, & Hartelius,
2010); counseling for psychological and family concerns; and lifestyle changes such as
exercises and environmental modifications (Ha & Fung, 2012; Nance, 2012). Though
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there is no cure for HD, Nance (2012) insists that when a patient receives a diagnosis for
HD, healthcare providers should emphasize, “There is never ‘nothing we can do’ for a
person with HD (p. 359).”
A clinical diagnosis can be made when chorea is found in an adult patient along
with changes in his or her behavior, cognitive capabilities, and/or mood (Nance, 2012). A
family history of HD can strengthen the diagnosis, but a genetic test can provide
undeniable evidence for this disease (Ha & Fung, 2012; Nance, 2012). Genetic testing is
especially helpful in situations involving non-paternity, de novo mutations, or masked
symptoms (Nance, 2012). For example, changes in behavior may be a normal part of
puberty even if the adolescent carries a HD mutation (Koutsis et al., 2013; Nance, 2012).
However, these behavioral changes may instead be masked symptoms of HD for some
prodromal individuals during young adulthood (Nance, 2012). Genetic testing may help
distinguish between the two possibilities, though it is recommended that testing for
juvenile HD only be pursued if the symptomatic adolescent has a positive family history
for HD (Koutsis et al., 2013).
HD is an autosomal dominant disorder that arises from having a CAG
trinucleotide expansion in the HTT gene on chromosome 4 (Ha & Fung, 2012;
Heemskerk & Roos, 2012; Koutsis et al., 2013; MacDonald et al., 1993; Shoulson &
Young, 2011). The resulting huntingtin protein has too many glutamines, changing
protein folding and disrupting several cellular processes (Bugg, Isas, Fischer, Patterson,
& Langen, 2012; Ha & Fung, 2012; MacDonald et al., 1993). Most individuals in the
general population have fewer than 26 CAG repeats in HTT and will not display the
disease (Semaka et al., 2012; Shoulson & Young, 2011). A premutation for HD is
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classified as having between 27 and 35 CAG repeats (Semaka et al., 2012; Shoulson &
Young, 2011). Individuals with this premutation are not at risk for developing HD, but
children of fathers carrying a CAG repeat size from 27 to 35 repeats are at risk for
inheriting an expanded CAG repeat sequence (Semaka et al., 2012). This phenomenon
known as anticipation, which is most often paternally derived in HD, can increase the
CAG repeat number in the children and, therefore, increase their risk of HD (Semaka et
al., 2012; Shoulson & Young, 2011). Individuals who have between 35 to 39 CAG
repeats will display reduced penetrance of symptoms, but individuals with 40 or more
CAG repeats have complete penetrance of Huntington disease (Ha & Fung, 2012; Roze,
Bonnet, Betuing, & Caboche, 2010; Semaka et al., 2012; Shoulson & Young, 2011).
Those with greater than 60 to 80 CAG repeats may experience juvenile HD (Koutsis et
al., 2013; Semaka et al., 2012; Shoulson & Young, 2011).
1.2 Genetic Counselors
Genetic counselors are healthcare professionals trained to help patients
understand the role of inheritance in genetic conditions and guide them through decisions
on genetic testing as well as supporting them through the complexities of diagnosis,
management, and coping with these medical disorders. Genetic counseling is the service
given to patients and their families that pertains to the specific genetic conditions they are
experiencing or for which they are at risk. As health professionals with training and
experience in the personal and emotional situations affecting the livelihood of their
patients, genetic counselors acquire a skill set that includes the ability to promote the
resilience and endurance of their patients in the face of new diagnoses and extreme
hardship.
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This definition for genetic counseling best describes the career of a clinical
genetic counselor; that is, a counselor who works in a clinical setting as opposed to in
another environment, such as a laboratory or a research institution. Furthermore, clinical
genetic counselors often refine their roles when they choose from a variety of medical
specialties such as prenatal counseling, cancer genetics, or neurogenetics. Thus,
individual genetic counselors are likely to routinely have certain counseling experiences
based on which patient populations they see. Clinical genetic counselors must develop
the ability to cope with various patient and counselor emotions, based on what disorders
they counsel for in clinic and how severe the outcomes may be for their patients.
1.3 Preparing for and Engaging with Patients
Genetic counseling for the at-risk HDBD patient population can be significantly
different from counseling other patient populations because the symptoms of dementia or
psychiatric disturbances may prevent the patients from understanding and directing their
own medical care appropriately (Goldman et al., 2011). As recommended by professional
practice guidelines written by Goldman et al. (2011), a family member or legal guardian
should be requested to accompany a HDBD patient to genetic counseling sessions. In
fact, encouraging the presence of a support person for the presymptomatic testing process
is part of the Guidelines for Genetic Testing for Huntington Disease published by The
Huntington Disease Society of America (Goldman et al., 2011; IHA & WFN, 1994).
These guidelines, written shortly after the identification of HTT as the gene responsible
for HD, are often used by genetic counselors when testing for other adult-onset genetic
disorders to help minimize the risk for severe psychological distress (Butler et al., 2011;
Goldman et al., 2011; IHA & WFN, 1994; Rahman et al., 2012).
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In addition to bringing a support person, the guidelines by IHA and WFN (1994)
describe a list of other recommendations. Many of these recommendations follow wellestablished genetic counseling practices such as respecting autonomy and providing
sufficient information for individuals to make informed decisions. Other
recommendations are more specific to HD testing, such as the need for counselors to be
in a multidisciplinary team, the necessary number of sessions, and the minimal time
interval required between them.
The authoring committee of these guidelines emphasized that “…the different
sections of these recommendations are inextricable parts of a whole.” These guidelines,
written with input from HD family organizations, are designed to safeguard patients at
risk for HD during presymptomatic testing. However, many genetic counselors may find
strict adherence to this set of instructions too burdensome for their presymptomatic HD
sessions, let alone for patients at risk for other HDBDs. This thesis will expound on the
different techniques that genetic counselors use with their patients at risk for HD as well
as other HDBDs.
1.4 Compassion Fatigue
Compassion fatigue is the state of being unable to act on behalf of a client to the
best of one’s abilities because of a drain on the medical professional’s empathy (Benoit,
Veach, & LeRoy, 2007). Compassion fatigue can prevent genetic counselors from best
serving their patients because of the counselors’ symptoms, which can include avoidance
behaviors and emotional disturbances (Benoit et al., 2007). The study conducted by
Udipi, Veach, Kao, and LeRoy (2008) found that nearly one in four genetic counselors
were at high risk for compassion fatigue.
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Genetic counselors who practice in predictive testing for HDBDs may be at
greater risk for compassion fatigue than genetic counselors who do not see this patient
population. This hypothesis comes from the idea that HDBDs are permanent, progressive,
and incurable disorders with tragic consequences, often with high inheritance risk and
symptoms that alter the very state of an affected individual’s mind. The devastating
nature of these adult-onset neurodegenerative disorders may predispose genetic
counselors who work with HDBD patients to be susceptible to compassion fatigue due to
the pressures and responsibilities of their job to provide empathy along with life-changing
information (Benoit et al., 2007). Udipi et al. (2008) found that compassion fatigue is
more likely to affect counselors who repeatedly expose themselves to distressed patients.
Thus, this thesis will attempt to answer the question: do genetic counselors perceive their
HDBD patients to be distressed and in need of extra empathy?
1.5 Perceptions of Genetic Counselors
The stress of testing for a HDBD and receiving these life-changing results can
threaten patients with increased anxiety, depression, and suicidal thoughts (Goldman et
al., 2011). However, more often than not, those who pursue genetic testing for AD, one
of the most recognizable examples of a HDBD, are not necessarily subject to severe
psychological impacts (Rahman et al., 2012). In fact, genetic testing can help patients feel
more in control of their health (Goldman et al., 2011; Rahman et al., 2012). After all,
those who pursue testing for dementia often claim that their chief reasons are to address
early symptoms, develop health and financial planning for themselves or their children,
eliminate uncertainty, and aid researchers (Goldman et al., 2011; Rahman et al., 2012). In
another study known as the Risk Evaluation and Education for Alzheimer’s Disease
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(REVEAL), there was no substantial increase in anxiety, depression, or test-related
distress measured in at-risk adults for AD who received presymptomatic testing for their
APOE ε4 carrier status, an allele that increases the risk for AD but does not guarantee the
development or absence of AD (Arribas-Ayllon, 2011; Galvin & Sadowsky, 2012;
Goldman et al., 2011; Holtzman, Morris, & Goate, 2011; Rahman et al., 2012).
Furthermore, by evaluating at-risk HDBD patients for stress levels before genetic testing
and referring for psychological or psychiatric assessments when necessary, severe
psychological impact can usually be avoided (Rahman et al., 2012).
But what do genetic counselors believe their patients at risk for HDBDs are
experiencing? After all, the uptake for genetic testing of HD and AD is lower than
expected. Surveys conducted before genetic testing for HD was available concluded that
5 to 7 out of every 10 individuals at risk for HD would want to undergo predictive testing
(Keenan et al., 2013). However, now that presymptomatic testing is available, fewer than
1 out of 10 Americans at risk for HD have pursued genetic testing (Shoulson & Young,
2011). This seems to indicate that a definite diagnosis for a HDBD is too unnerving for
some individuals to accept (Tibben, 2007). Is this how genetic counselors see their
patients?
The low uptake rate may not be the only reason that genetic counselors could
have a different view of individuals at risk for HDBDs as opposed to other patient
populations. It has been documented that depression can threaten many individuals with
terminal dementia, and sometimes depression itself can mimic the symptoms of dementia
(Goldman, 2001; Holtzman et al., 2011). This can cause a misdiagnosis for AD, often by
the patients themselves, when in fact they are only depressed (Goldman, 2001; Holtzman
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et al., 2011). This pursuit to find proof of a disease within oneself can be known as
symptom-seeking behavior (SSB) (Wain, Uhlmann, Heidebrink, & Roberts, 2009). For
example, Goldman (2001) describes a patient who was distressed because she believed
that her forgetfulness was due to AD, which she believed she had inherited from her
father who developed AD before the age of 65 years. Neuropsychological tests revealed
that her memory failings were more likely due to depression than AD (Goldman, 2001).
Wain et al. (2009) further suggests that stress levels are high for patients with a family
history of early-onset Alzheimer disease (EOAD) which, by definition, presents with
symptoms before 65 years of age.
Perhaps the high level of stress, the seeming predisposition to depression, and the
SSB result from the fear of HDBDs, such as HD and AD, because of the severity of
symptoms and the lack of treatment or cure. These factors, combined with a relatively
high penetrance and inheritance risk, can create family-wide dynamics with unique
situations and emotional issues for genetic counselors to handle. How do these factors
affect the perceptions made by genetic counselors of their patients living at risk for
HDBDs?
1.6 Rationale
HDBDs, such as HD, are present at rates comparable to other inherited disorders
for which genetic counselors frequently provide genetic evaluation and counseling;
however there are relatively few genetic counselors who see patients at-risk for HDBDs.
For example, approximately 30,000 people in the U.S. have HD, and up to 200,000 are
living at risk (HDSA, 2011). In contrast, only 1.5% of the genetic counselors who
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participated in the 2012 NSGC Professional Status Survey reported neurogenetics as their
primary specialty (NSGC, 2012).
The need for more of these professionals to counsel this patient population is
apparent. However, the literature available about how these genetic counselors work with
their patients and what lessons they have learned is, to some extent, lacking. This thesis
project may be able to provide guidance to genetic counselors new to this patient
population and provide a framework so that they are at lower risk for compassion fatigue.
1.7 Purpose
This study is intended to benefit both counselors and their patients by providing
counselors an opportunity to share their knowledge and understanding with the medical
professionals who work with patients at risk for HDBDs. These patients and their
families can benefit over the long-term, as the results of this study may help provide a
framework to counselors entering this field by recognizing verified methods of
counseling.
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Chapter 2: Manuscript
Working with Patients at risk for Hereditary Degenerative Brain Disorders1
2.1 Abstract
Hereditary degenerative brain disorders (HDBDs) are a unique class of genetic
conditions that result in progressive loss of function within the nervous system, many of
which present during adulthood. Given this, the diagnosis of a HDBD can be daunting for
both the patient and the genetic counselor assisting in medical care. The purpose of this
study was to find themes among genetic counselors who see this patient population and
help provide a framework to counselors entering this field by recognizing verified
methods of HDBD counseling. Sixteen genetic counselors who routinely see patients atrisk for HDBDs were interviewed concerning how they prepared for and engaged with
their patients, how they handled the complex emotions frequently associated with
presymptomatic HDBD counseling, and how they perceived the stress levels and coping
mechanisms of their patients. The results of this study showed that genetic counselors
who see patients at risk for HDBDs utilize agendas and/or protocols in preparing for and
directing sessions. Additionally, these genetic counselors perceive their HDBD patients
as capable of coping with their own presymptomatic testing results. There was not
enough evidence from this study to determine if genetic counselors who see patients at
risk for HDBDs are at any greater risk for compassion fatigue than other genetic
counselors. Overall, the genetic counselors who see patients at risk for HDBDs are more
1

White, S.J., Abramson, R., Fox, M., Goldman, J.S. To be submitted to Journal of Genetic Counseling.
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similar to than different from genetic counselors who do not see this patient population.
Given that a significant number of people are living at risk for HDBDs, experiences in
case observation and counseling alongside expert HDBD counselors could benefit genetic
counselors and the patients they serve.
Keywords: Hereditary degenerative brain disorders, Huntington disease,
Alzheimer disease, adult-onset neurodegenerative disorders, presymptomatic genetic
testing, genetic counseling
2.2 Introduction
Hereditary degenerative brain disorders (HDBDs) are a unique class of genetic
conditions that result in progressive loss of function within the nervous system. In many
of these disorders, such as Alzheimer disease (AD), amyotrophic lateral sclerosis, or
frontotemporal dementia, the affected individuals experience physical and/or mental
regression as the brain degenerates during adulthood. Given this, the diagnosis of a
HDBD can be daunting for both the patient and the genetic counselor assisting in medical
care. Huntington disease (HD) is a HDBD and an ideal model genetic disease for this
study as the guidelines for the molecular genetics predictive test in Huntington’s disease
(IHA & WFN, 1994) provide a widely accepted model for presymptomatic testing for
other adult-onset disorders (Goldman et al., 2011; Guimarães et al., 2013)
HD is an autosomal dominant disorder defined by motor deterioration and
dementia accompanied by behavioral changes (Ha & Fung, 2012; Shoulson & Young,
2011). Chorea may start in the distal limbs and in the facial muscles (Ha & Fung, 2012).
Over time, chorea may decrease, and increased rigidity and dystonia become more
pronounced (Ha & Fung, 2012). Throughout the course of the disease, features such as
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bradykinesia, ideomotor apraxia, motor impersistence, dysarthria, and dysphasia may be
present (Ha & Fung, 2012; Heemskerk & Roos, 2012). Progressive loss of executive
functioning, attention, visuospatial and construction skills can occur from dementia (Ha
& Fung, 2012). Behavioral changes such as irritability, aggression, psychosis, and
sometimes suicidal ideation may be present at any time during the disease (Ha & Fung,
2012). There is no cure or treatment to stop the progression of HD, and death tends to
occur between the first and second decade after the onset of HD (Heemskerk & Roos,
2012; Keenan et al., 2013; Nance, 2012; Semaka et al., 2012).
Though a clinical diagnosis for HD is sufficient, genetic testing is available (Ha &
Fung, 2012; Nance, 2012). HD results from having a CAG trinucleotide expansion in the
HTT gene on chromosome 4 (Ha & Fung, 2012; Heemskerk & Roos, 2012; Koutsis et al.,
2013; MacDonald et al., 1993; Shoulson & Young, 2011). Most individuals in the general
population have fewer than 26 CAG repeats in HTT and will not display the disease
(Semaka et al., 2012; Shoulson & Young, 2011). Individuals who have between 35 to 39
CAG repeats will display reduced penetrance of symptoms, but individuals with 40 or
more CAG repeats have complete penetrance of Huntington disease (Ha & Fung, 2012;
Roze et al., 2010; Semaka et al., 2012; Shoulson & Young, 2011). Those with greater
than 60 to 80 CAG repeats may experience juvenile HD (Koutsis et al., 2013; Semaka et
al., 2012). The age of onset of HD can be quite variable among individuals and is
frequently family specific, with the mean age of onset about 40 years (Ha & Fung, 2012;
Heemskerk & Roos, 2012; Myers et al., 1982).
Genetic counselors are healthcare professionals trained to help patients
understand the role of inheritance in genetic conditions and guide them through decisions
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on genetic testing as well as supporting them through the complexities of diagnosis,
management, and coping with these medical disorders. As health professionals with
training and experience in the personal and emotional situations affecting the livelihood
of their patients, genetic counselors acquire a skill set that includes the ability to promote
the resilience and endurance of their patients in the face of new diagnoses and extreme
hardship. Genetic counselors who practice in predictive testing for HDBDs may be at
greater risk for compassion fatigue than genetic counselors who do not see this patient
population.
Compassion fatigue is the state of being unable to act on behalf of a client to the
best of one’s abilities because of a drain on the medical professional’s empathy (Benoit et
al., 2007). Compassion fatigue can prevent genetic counselors from best serving their
patients because of the counselors’ symptoms, which can include avoidance behaviors
and emotional disturbances (Benoit et al., 2007). The hypothesis that genetic counselors
who see at-risk HDBD patients are at a higher risk for compassion fatigue comes from
the fact that HDBDs are permanent, progressive, and incurable disorders with tragic
consequences, often with high inheritance risk and symptoms that alter the very state of
an affected individual’s mind. The stress of testing for a HDBD and receiving these lifechanging results can threaten patients with increased anxiety, depression, and suicidal
thoughts (Goldman et al., 2011). Symptom-seeking behavior (SSB), the anticipation and
self-diagnosis of disease onset, can sometimes present itself in at-risk individuals (Wain
et al., 2009). The uptake for genetic testing of HDBDs is relatively low; in fact, fewer
than 1 out of 10 Americans at risk for HD pursue genetic testing (Shoulson & Young,
2011). This seems to indicate that a definite diagnosis for a HDBD is too unnerving for
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some individuals to accept (Tibben, 2007). Furthermore, the symptoms of dementia or
psychiatric disturbances may prevent the patients from understanding and directing their
medical care appropriately (Goldman et al., 2011). Altogether, the devastating nature of
these adult-onset neurodegenerative disorders may predispose genetic counselors who
work with HDBD patients (and thus repeatedly expose themselves to distressed patients)
to be susceptible to compassion fatigue due to the pressures and responsibilities of their
job to provide empathy along with life-changing information (Benoit et al., 2007; Udipi
et al., 2008).
There are relatively few genetic counselors who see patients at risk for HDBDs.
In fact, only 1.5% of the genetic counselors who participated in the 2012 NSGC
Professional Status Survey reported neurogenetics as their primary specialty (NSGC,
2012). The need for more of these professionals to counsel this patient population is
apparent. However, the literature available about how these genetic counselors work with
their patients and what lessons they have learned is, to some extent, lacking. In this study,
genetic counselors who routinely work with this patient population were interviewed and
asked to answer how they prepared for and engaged with their patients, how they handled
the complex emotions frequently associated with presymptomatic HDBD counseling, and
how they perceived the stress levels and coping mechanisms of their patients. This
interview study may be able to provide guidance to genetic counselors who are new to
presymptomatic HDBD counseling and provide them with a framework so that they are
at lower risk for compassion fatigue.
Our hypotheses for this study were as follows: Genetic counselors who serve
patients at risk for hereditary degenerative brain disorders (1) utilize agendas/protocols in
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preparing and directing sessions, (2) are at a significant risk for compassion fatigue, and
(3) perceive their patients as being unable to cope with the information presented during
genetic counseling sessions. Significant differences may be seen among genetic
counselors who see at-risk HDBD patients as a single provider and those who see at-risk
HDBD patients as part of a HDBD interdisciplinary clinical team.
2.3 Materials and Methods
The institutional review board at the University of South Carolina approved this
study in September of 2012. Genetic counselors who were members of the National
Society of Genetic Counselors (NSGC) Neurogenetics Special Interest Group electronic
mailing list were invited by email to participate in this interview study. Other genetic
counselors, including personal contacts or counselors participating in the Dominantly
Inherited Alzheimer Network study were also sent the same invitation to participate.
Later in the study, two e-blast email invitations were sent to the entire NSGC electronic
mailing list inviting all counselors with experience counseling patients at risk for
HDBDs. Counselors who responded to the primary author arranged dates and times to
conduct interviews.
The interviews took place over the phone, Skype, or Adobe Connect, the latter
two being different internet-based conferencing media. The medium used was based on
the preference of the participant. Audio content of the interviews was recorded for
analysis, and no video content was recorded of participants using either Skype or Adobe
Connect. Participants were informed of these recording conditions ahead of the interview.
The identity of each genetic counselor has been kept confidential. Numerical
codes were assigned to each of the 16 participating genetic counselors. All transcripts
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were void of names. Only the primary author had access to identifying information in the
original transcripts. The audio and coded lists of the interviewees were stored in separate
documents secured in a password-protected laptop. No identifying information was
shared during the qualitative analysis in order to protect the privacy of the participants.
The interview questions began with quantitative, closed-ended questions and
proceeded to qualitative, open-ended questions (See Appendix). All interviewees were
asked the same questions in the same order. Any question that needed to be clarified was
done so in a consistent fashion by the primary author. Questions that required additional
examples to add context were done so in a consistent fashion by the primary author. Each
interviewee was allowed to elaborate on any question as she chose. Additional questions
were asked based on the flow of conversation, but may not have been added to the study.
Interviews ranged from 22 to 53 minutes in length.
The qualitative analysis software Atlas.ti 7.0 was used to store and organize data
as well as transcribe audio to text. Interviews were transcribed in accordance with simple
transcription procedure (Thorsten Dresing, 2012) near verbatim, excluding words and
phrases not contributing to answering study questions. Due to a recording error, one of
audio recordings of the participants was never recovered. The participant was informed
and agreed to check and verify her statements transcribed by the primary author during
and shortly after the interview as well as add any missing information. This qualitative
study used methods based on grounded theory, a widely used methodology for genetic
counseling research (Grubs & Piantanida, 2010).
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2.4 Results
A total of sixteen (N = 16) genetic counselors from the United States and Canada
participated in this study. Participants were asked to identify their practice specialties,
which included prenatal, pediatric, cancer, general genetics, research, and neurogenetics
(see Table 1). Three participants chose two primary specialties, and in each of these
cases, neurogenetics was one of the specialties. In total, half of the participants (n = 8)
considered neurogenetics to be, at least in part, their primary specialty. Most participants
(n = 11) had more than 10 years of experience in genetic counseling. For half of the
participants (n = 8), HDBD cases made up less than 25% of their total caseload when
compared to other specialties, such as pediatric or prenatal cases. However, all
participants (n = 16) currently see HDBD patients. Most participants (n = 12) considered
themselves part of a HDBD interdisciplinary clinical team. Only one participant evaluates
patients’ stress levels with a structured questionnaire, and a minority of participants (n =
5) use standard measures for anxiety and/or depression with patients at risk for HDBDs.
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Table 1: Demographics of Practice Information of Study Participants
Study Participants (N = 16)
Practice Specialty*
Prenatal
Pediatric
Cancer
General genetics
Research
Neurogenetics
Length of Practice
0-5 years
6-10 years
11-15 years
16-20 years
21 or more years
Percentage of caseload is for HDBD patients
≤25%
26-50%
51-75%
≥76%
Part of a HDBD interdisciplinary clinical team
Yes
No
Currently see HDBD patients
Yes
No
Evaluate HDBD patients' stress levels with structured questionnaire
Yes
No
Use standard measures for anxiety and/or depression with HDBD
patients
Yes
No

n (%)
2 (13%)
3 (19%)
1 (6%)
3 (19%)
2 (13%)
8 (50%)
2 (13%)
3 (19%)
3 (19%)
1 (6%)
7 (44%)
8 (50%)
2 (13%)
2 (13%)
4 (25%)
12 (75%)
4 (25%)
16 (100%)
0 (0%)
1 (6%)
15 (94%)

5 (31%)
11 (69%)

*Percentages do not add up to 100% due to three participants choosing two primary practice specialties

2.4.1 What do you to prepare for a session with an individual at risk for a
HDBD? As might be expected, the way the participants prepare for a session with an
individual at risk for a HDBD is similar to the preparation of any genetic counselor
before a session. Most participants (n = 12) described obtaining and reviewing the
20

medical records and family history. Five participants mentioned they may request
additional records on family members to confirm the genetic mutation that their patient
may have inherited. Other preparations may come through attending disease-specific
meetings, reviewing the medical literature, or readying resources for the patient. Half of
the participants claimed to call the patient before the first clinical session to discuss topics
such as the patient’s expectations of presymptomatic testing, their reasons for wanting
testing, their experience with the genetic disorder in question, and/or details about their
support network. A few genetic counselors used the pre-visit phone call to anticipate
possible needs and concerns a patient could bring to the session and/or anticipate what
referrals might be necessary.
Two of the participants, both with more than 10 years genetic counseling
experience, made it clear that they needed minimal preparation for presymptomatic
HDBD sessions. Participant #8 claimed that because of her many years of experience, she
was, “…more involved in getting a good sense for the patient than in doing any type of
literature reviews unless something in particular comes up.” Participant #16 explained,
“…I've been doing it enough times, long enough now, that I don't really sit and prepare
what I'm going to say or those kinds of things so much anymore.” However, most
counselors claimed that HDBD sessions required some degree of preparation.
2.4.2 How do you direct a session with an individual at risk for a HDBD?
When discussing how a genetic counselor may direct a session, two major categories
seemed to emerge: what parts make up a session and how to use an agenda. The parts of
the session will appear familiar to all genetic counselors: contracting, gathering
information from the patient, educating, and counseling. Many counselors made special
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note of gathering information about why their patient wanted presymptomatic testing,
what their expectations were of the testing protocol, and what their prior experience with
the HDBD in their family was.
All but two participants stated their use of some form of check list, protocol, or
agenda to structure their HDBD sessions. How they used this agenda seemed to reflect on
their idea of who was directing the session. A majority of participants spoke of modifying
agendas to complement the individuality of their patients. For example, Participant #11
stated the following:
Yeah, I mean, I would say that we have an agenda of points that we want
to make sure that we hit. But how much time we spend on each of those
points and what information is covered in what detail is basically patient
led. So it's kind of, it's both.
Several participants wanted the patient’s questions and concerns to direct the session. As
Participant #13 stated, “I have kind of a list of things that have to be covered, but I start
out with letting them direct the session and then I fill in what doesn't come up.” Other
participants described using detailed agendas that could be modified for patients, but their
adherence to these outlines was more consistent as this quote from Participant #3
portrays, “And I do try to let it be somewhat patient controlled or directed, but I also have
my own agenda as well so I do just try to find the compromises in that.” Overall, the
desire of genetic counselors to use the agenda as a means to meet the needs of the
patients was consistent among participants.
2.4.3 How do you handle the patient’s needs versus the patient’s family’s
needs? Participants seemed to address this question from three different approaches that
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became the main themes: (1) what counseling strategies are used to resolve family
conflicts, (2) how involved was the family member, and (3) whose needs were priority?
When this interview question was asked, the primary author always paired it with the
following example. The participant was told of a situation in which their patient at risk
for HD had a parent who did not want to know his or her own HD carrier status. The
participants were then asked what they would do under such circumstances.
The first theme consisted of several counseling strategies. These included asking
about the relationship and situation between the conflicting family members, giving extra
time for the family to make a decision, and/or making referrals for professional
counseling. Over half of the participants (n = 9) mentioned that they would encourage
their patient to discuss these issues with their parent.
The second theme concerned how involved the parent was in the counseling
process. Half of the participants spoke of bringing the family member into the session or
arranging for a separate counseling session. Some would talk to both parties
independently as individual patients, and others might try to facilitate a contract between
the family members. For example, Participant #13 said, “We try to have the two family
members make a contract with one another about how they're going to handle
information flow within the family.” A few counselors spoke of trying to get the parent
tested first instead of their original patient. According to Participant #4, “If possible, have
parent get tested instead so children won't have to be tested if test negative.”
Concerning the other aspect of the second theme, if the patient did not involve the
parent in a counseling session, then a few of the participants voiced that they would make
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sure the patient was aware of how going through with predictive testing could negatively
affect that relationship. As Participant #7 stated:
The patient in front of me is always the person that I'm most directly
concerned with and would then make sure that that patient was aware of
what actions may affect other family members and how: so how testing
that person might provide information to the parent without them
anticipating those consequences and how that could maybe be dealt with
by talking to the father or getting an idea of what communication lines are
open between them already.
In reference to the third theme, many of the participants stressed the importance
of aiming for compromise. However, if no compromise could be reached as in the
quotation above, all but three participants spoke of how the patient’s needs take priority.
That is, most of these genetic counselors would pursue presymptomatic testing for their
patient even if the parent disagreed. Participant #8 further elaborated this concept, “I treat
the patient's needs as...they are the determining factor, but we do discuss the family needs
and I try to work it so that we respect everyone's needs. But ultimately, the patient's needs
and decisions are paramount.” Participant #16 hesitated with this line of thinking. When
the primary author asked her if she would still allow for testing when no compromise
could be found, she responded, “We have. Could I say that I always will? I don't know
that I can, but I can tell you that we have done it.” Out of the three participants who did
not state that they would continue to pursue testing under these circumstances, one of
them, who worked in a research setting, stated that she would release the patient from the
study, and the other two did not specify how they would resolve the impasse. Participant
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#16 had previously explained, “…it's hard. It's not easy. Whatever, you know, there's no
right answer for those.”
2.4.4 Questions concerning HDBD testing results.
2.4.4.1 How do you give results for genetic testing, both positive and negative?2
Several recurring ideas seemed to define how participants would address this question,
including when and where to give results, the utility of planning ahead, and how involved
phone communication was. All participants routinely give results to patients at a later
genetic counseling session. Minor differences existed on how to give the results during
the session, such as what patient-friendly language to use or who else would be present at
the results disclosure. Whatever the differences were, planning the results session seemed
to be important to the participants. Participant #13 noted that planning ahead was
important to the patient also:
I recommend that they have a plan in place about what the expectations of
people in their families and their support system know about when they're
getting their results so that, you know, if there's 10 people on their list who
are imminently waiting to hear their results, they have a plan about how
that's going to happen because I think people for the most part are not very
good about predicting how they feel afterwards.
Perhaps the most surprising comments arose on the use of phone communication.
Most counselors were quick to state that they would not call patients with positive or
negative results, but that patients were expected to come in for their results during a later
session. A few participants (n = 4) made concessions that they would give results for rare

2

Codes between the first and second part of question four were sometimes used interchangeably given their
similarities and proximity to each other during the interview.
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exceptions, such as for patients who were separated by significant geographic distance
across states and countries. One participant noted that she disapproved of colleagues that
would give negative results over the phone.
Two participants favored re-visiting the idea of calling out results to these
presymptomatic patients. Participant #5 said it this way:
In our hospital, we do require a post-test face-to-face visit, which I find
very frustrating, I'll be honest. We do do that. We say, you know, “It's
better to give results in-person.” I actually personally disagree…I just
think it's too hard to give results in-person because people don't have time
to process the information and ask questions versus, even in prenatal, in
the prenatal world...the genetic counselor will call out abnormal results
over the phone and then schedule a visit for the next day, which I think
would make a lot more sense if patients had time to hear the news and let
it sink in. Even one day is not long a time to process the information, but
enough time to get over the initial shock and then say, "Okay, now what?"
You know, it's hard. I've had not a lot, but I've had a handful of patients
just walk out of the room. It's just like, "I can't hear anything you have to
say. I will call you later." and they leave. And it's SO hard, because I want
to be like, "No, just sit here for a minute." But it just doesn't, they just shut
down.
2.4.4.2 How does giving results for a HDBD differ from giving other genetic test
results, if at all? Many participants seemed to believe that giving results for HDBDs
could differ from giving results for other genetic tests due to the very nature of the
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disease and because of the particular counseling responsibilities required; however some
participants also remarked on the similarities between all genetic test result disclosures.
Many participants stated or implied that, by nature, HDBDs are more intense than other
genetic diseases. Participant #16 described this theme with her answer, “Yeah, I don't
know. I would just say it is more intense. That's what I can tell you.” During the
interviews, participants recognized that HDBDs can affect the mind, but there is no cure
and there are no effective treatment options. Other participants talked of how giving these
results were different in that these at-risk individuals were presymptomatic and this
information impacted their whole future. Participants described giving these results as
“life-altering” (P#9), “…like you’re giving them a death sentence” (P#2), and that the
example of HD has, “…a very, very severe phenotype” (P#15). Participant #13 stated that
“…there's a lot more anxiety.” Participant #10 spoke of the need for extra support for
those receiving these results:
I don't think in any other testing situation do we really require them to
bring in somebody else in with them because we know the significant
psychological magnitude of the reaction and what it could potentially lead
to. That's why we screen very carefully looking for the depression and the
suicidal ideation.
Participant #5 summarized a lot of the participants’ feelings in her quote:
In this situation, I feel like there's a big difference between telling
somebody that they're going to, you know, be at risk for some condition
where there is medical treatment, or that it's going to affect their health but
not their mind. When you affect your mind, it's scary. I mean, I think
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there's a whole level more of the uncertainty and "How do I know?" and
"I'm going to worry every time I forget." You know, I mean, we all have
those moments: you walk into a room and you're like, "Alright, what was I
supposed to do here? I forgot... I was doing something." And people who
are at risk for these types of conditions, they find those things so much
more stressful. It's that other element of your mind. It's different. I also
feel like for a lot of these hereditary degenerative brain diseases there's not
a lot of treatment options. There's not much we can do today for a lot of
them and that's hard.
Continuing on the theme of the nature of HDBDs and test disclosure, some
participants took special notice of how HDBDs are inextricably tied to the family. Many
HDBDs are autosomal dominant, and thus numerous patients have seen the disorder in
their family before. Because of this, patients seem to know what to expect, as Participant
#16 describes, “It's a, you know, a future that usually people have witnessed, you know,
with their parents or have ‘Googled’ and like, you know, are like imagining the worst.”
Participant #9 gave the example of HD and said, “…because most of these families have
seen it already, it just changes their whole outlook, you know?” Leading up to the results
disclosure, there can be a “buildup” to the dreaded family disease. Positive results have
an impact on the rest of the family as well. When Participant #13 compared this to giving
results in pediatric genetic counseling in which the patient is displaying unique
symptoms, she said this:
It's a very different dynamic than a family where they know what it is and
the whole buildup about the testing is finding out if they have what they’re
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dreading or not and the ripple effect of that result through their life and
their family's life and their whole future. So there's a lot more anxiety.
There's a lot more buildup to getting the results. It's just a really different
dynamic than in individuals who they're already dealing with something.
The other theme that emerged was that the counseling responsibilities differ when
giving these results. Six participants noted here that these results cannot be given over the
phone, and one participant noted that there was more telephone contact with the patient
overall. Participants noted the extra disclosure session, the increased follow-up, and the
coordination of bringing a support person, all of which can require more planning. One
participant noted that the sessions are less about symptoms and more about psychosocial
issues, which changes the level of counseling indicated.
That being said, not all participants agreed that giving HDBD results was much
different from giving other genetic test results. Many participants recognized that HDBDs
are hardly the only genetic disorders to be difficult to accept. Participant #16 exclaimed
that giving any bad news, “sucks.” Participant #11 admitted that, although giving HDBD
results can be somewhat different, “…the raw emotion that comes out of getting, you
know, an upsetting test result is, you know, is pretty universal.” Participant #1 was
reluctant to compare giving HDBDs results to all other possible genetic tests, “But there's
many genetic conditions that are, you know, that I'm sure people look at as equally
devastating in many ways, so it really depends on the condition that we're talking about.”
Though most participants would agree that some degree of difference exists, many did
not want to single HDBDs out as having the absolute worst possible test disclosures.
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2.4.5 Do you prepare yourself emotionally for a session with an individual at
risk for a HDBD? Out of the 16 participants, 12 claimed that they prepare emotionally
for a session on some level. How they prepared seemed to consist either of practical or
emotional solutions. Practical solutions were often implemented before a session. Some
examples included reviewing the patient’s chart and family history, creating a list of
talking points, using the pre-visit phone call to anticipate difficult patients, setting aside a
“quiet time” (P#13) before the session, and preparing for possible scenarios. Two
participants scheduled HDBD cases so that they were not consecutive, that is, they would
not have to go directly from one HDBD session to another. Another participant would not
look at the results until just before the session so that she would not dwell on the results.
Three participants mentioned talking with other staff members to receive emotional
support.
Participants often had emotional solutions to help themselves prepare for a
session. When asked if they prepared emotionally, several participants had memorable
quotations about how to do this. Participant #8 said,
Oh, yes! They can be quite heavy. You know, I really just kind of gear
myself up for it. I don't do anything in particular except to realize that
what I'm walking into could be a heavy situation and so, "Let's go with it!"
Participant #9 answered, “Yes, I do. I have to every time. And, you know, I've given
hundreds of results. But, you know, I have to have my counselor face on.” Participant
#11 said, “…the geneticist and I kind of mentally prepare and kind of have to steel
ourselves to be ready for that session.” Participant #16 answered, “Oh, absolutely. Yeah,
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put on a little bit more armor. You know, you get more emotionally prepared to sort of be
able to handle whatever comes back at you.” Participant #2 answered thoroughly:
So yeah, you do emotionally prepare yourself, mentally also. I mean, you
have to think, think about what the patient's going through. Wow, you
know, they're coming to potentially find out if they're going to have this
life-changing condition and you are going to be the one to tell them that.
That's pretty profound. But also there has to be a little bit of separation.
You can't wrap all of that up and carry it yourself because that's a huge
burden, too. So I don't know that any counselor has that completely
perfected. We always want to care deeply but we have to somewhat
separate ourselves emotionally. So definitely an ongoing challenge.
Four of the participants agreed that they may prepare emotionally, but it would be
conditional. Participant #5 prepared more for positive result disclosures:
I get more nervous when it's positive results, you know, just since I know
it's going to be difficult. But for the first visit I don't do a lot…I just try to
be the most prepared. I mean, I think that's how I feel more comfortable is
just knowing that I am the most prepared I can be.
Other answers included only preparing emotionally at the results disclosure or preparing
as much for HDBD sessions as with any other genetic counseling sessions. Still another
participant stated that the emotional preparation depended on extent of her relationship
with the patient. Though the emotional preparation for these four participants was
conditional, it seems that all the participants agreed that they prepared emotionally for
HBDB sessions sometimes.
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2.4.6 How do you handle emotions during the session, both that of yours and
your patient’s?3 The most common theme for how participants handled emotions during
their sessions was to be supportive of their patients (n = 15). Other common themes
included letting patients have their emotions (n = 14), counselors holding back their own
emotions (n = 11), counselors showing their own emotions (n = 7), and how to help
patients long-term (n = 7).
Participants most often described how they would support their patients when
they became emotional. Many of their techniques look similar to those of other
counseling sessions. Participants may remind patients of their reasons for testing, reframe
questions to suit the patient, talk through fears, encourage coping mechanisms, clarify
misconceptions, and allow time for emotions, questions, and reactions. Some participants
described themselves as compassionate, would try to understand where the patient was
coming from, would develop rapport, and would try to address the cause of the emotions.
Within this theme of showing support, seven participants expressed how they can
give their patients long-term support. Participants may offer resources such as support
groups, make referrals for additional counseling, or plan follow-up sessions or phone
calls. Participant #11 even mentioned rescheduling appointments for patients, “who are
just like shut down and don't want to talk.” Though supportive techniques may differ as
well as their timing, Participant #2 describes this as an evolving process for all
counselors, “handling patient emotions, I think that's a skill that every counselor has to
work on and continually develop.”

3

Quotations for this question could be derived from the answers to question 5, especially since the primary
author often inferred that these two questions were linked. e.g. “Along the same lines, how do you handle
emotions during the session, both that of yours and your patient's?”
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The second most common theme was, as Participant #5 said, “let people have
their emotions.” Participant #5 goes further to explain:
If they're mad, let them be mad. It's appropriate to be mad…I think I just
try to stay calm…I just validate. You know, most of the feelings that
people have are completely appropriate and so just let them feel that way.
And let them know, you know, of course they should be upset and mad
and life's not fair and all those things that people say… [I] try to keep my
emotions out of it. I've been affected by things people say and I just tell
them, you know, "Wow, that's really awful", and, you know, just be real.
Several participants made it clear that emotions are appropriate and that they try to
normalize feelings. Other participants spoke of being attentive to the needs of the patients
and to give patients extra space or time if needed.
The third most common theme, which 11 participants voiced, was that counselors
should hold back their own personal emotions. The underlying reason seemed to be that
the patient should not have to be burdened by the counselor’s emotions, as Participant #1
describes:
There are times when I tear up if it's a very sad discussion. And I really
don't go beyond that. I do everything in my power because I don't want my
patients to have to take care of me. That is not okay with me.
Participant #6 echoed this concept and the need to stay reserved for the patient:
I have not had a situation yet where I myself have broken down with
emotions because I feel that is not clearly my job. My job is to be strong
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and just accept whatever response they have and be there to be supportive
and, you know, sort of a safe zone for them to react.
Several counselors agreed with the need to stay calm for the patient and to not let
personal emotions get in the way. Sometimes this required mental preparation such as
when Participant #16 reminds herself to keep her emotions, “in perspective that, you
know, this isn't about you. It's about them at the moment while you're in the room with
the patient.” Sometimes it requires taking a break from the session or to relinquish the
session to another health professional who is in a better position to remain neutral.
However it is done, many participants find ways to hold back their own emotions from
the patient.
However, not every participant believed that all emotions should be held back.
Specifically, seven of the participants admitted to tearing up or crying with patients in
emotional situations. Participant #9 describes such a transition between holding back
personal emotions to crying with patients:
I'm pretty seasoned professional, and you know, I keep my emotions in
check but I think it's probably clear to people when they get to me. I was
trained never to cry in front of a patient. I think that that's wrong. I think it
should be done rarely, but there's a couple of times, particularly some of
these families I've now seen and tested three generations of family
members. And so I know their story. I know what happened. And so and
one more test positive and you might cry with them because it is sad.
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Two participants further elaborated that counselors should allow themselves to be
genuine to themselves and to their patients. Participant #8 gave another example of not
only handling patient emotions, but also her own:
You know, often times the patients cry during my sessions. I think it's
inherent in their concern for having inherited this devastating neurologic
disorder that's progressive and they've seen many of their family members
get it so often they do cry. I hand them a tissue. You know, I am empathic
and understand that this is scary. And I try to let them feel their emotions
where, you know, instead of deflecting it with humor or something I want
them to know that I recognize as well that this is scary. This is important.
This could be life-changing and it is important so it's okay if their
emotions are involved. And for myself I really try not to show my
emotions too much, but you know, if I tear up, I tear up. I don't hide that. I
think it shows that I'm human.
When handling emotions during a session, a counselor can help patients not only by
being supportive and letting people experience emotions, but also by sharing emotions
with patients as Participant #2 summarized:
I will say I have definitely cried with patients. And I don't know that that's
bad. The patients that I have gotten emotional with I feel like expressed
appreciation and expressed to me, "Wow! It's so nice to feel like you're
connecting with us and you understand how hard this is for us." … I just
sort of felt like, what would I do if this was my friend, you know? What
would I do? And sometimes that's giving them a hug. Sometimes that's cry
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with them. Sometimes that's just sorting it all out with them, putting things
in perspective. You know, there's different coping mechanisms that we all
have and that we encourage our patients to use. But we're all human and
so I think connecting is not always a bad thing. Being emotional is not a
bad thing. But sometimes it's just giving them the chance to be emotional.
I find that a lot of patients at risk for Huntington's, they just kind of go
about their day everyday and shove it off to the side. It's always in the
back of their mind, but they're never going to let it surface. Sometimes
when they're sitting with you in that office they do, for that hour, let it
come to the surface. And that's an emotional thing. And just letting them
cry or letting them be angry, letting them be so mad that this is happening
in their family is cathartic for them and definitely, I think, healing for the
counselors, too.
2.4.7 What do you do if you cannot keep from “taking the session home” with
you? Who do you talk to?4 Participants took this opportunity to talk about how difficult
situations can arise from their work as well as the activities and thoughtful solutions they
use to alleviate the stress of “taking the session home.” Most participants seemed to
acknowledge that “taking the session home” does happen at least occasionally. Some are
affected more than others. Participant #1 said:
Oh, I do take sessions home with me. I don't leave stuff at the door. I don't
think that's possible. I think about things all the time. I dream about things.
4

The first part of this question was always asked, but the second part of “who do you talk to?” was only
asked if the participant did not mention whether or not they spoke to anyone to deal with the issue of
“taking the session home”. One participant answered part of this question in the prior question, “How do
you handle emotions…?”
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I'm not one of these people who turns it off when I walk out the door. I
don't think many of us are.
“Taking the session home” does happen, and there are innumerable ways
genetic counselors deal with it. Almost all of the participants (n = 15) said that
they would talk to their colleagues, and most of them said this during the
interview without any prompting (see previous footnote). Half of the participants
would talk with their friends or family members, and one participant consulted
with a personal counselor if needed. Participants described activities to take their
minds off of the session. These could include things such as listening to music,
relaxing at home, going to the movies, or getting time alone. The most common
activity cited was getting exercise (n = 7).
Participants thought of several thoughtful solutions to combat “taking the
session home.” Preventative solutions included protecting oneself from emotions
before and during the session. After the session, participants may use techniques
learned from graduate school to take control of feelings, use the time to think of
ways to help the patient, or process the feelings in another way. Participant #5
spoke of a mentor who reminded her, ‘“It's hard, but you have to realize it's not...
you didn't cause these results to be positive,’ which obviously you know
cognitively, but emotionally it's hard to feel that way.” Many participants
recognized the potential of letting themselves “take the session home,” but many
also recognized as Participant #8 did, “You discuss it and you've got to move on.
It's hard.”
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2.4.8 How do you believe your patients handle being at risk for a HDBD?5
Participants believed that their patients could live with uncertainty well or poorly, often
based on the individuality of the patient, but many also concluded that these individuals
are a self-selected population and that we have limited knowledge of patients who are
living at risk yet do not come in for genetic counseling. Altogether, 10 participants
praised their patients for living with uncertainty well. Participant #9 stated, “I think they
handle it pretty well. I give them a lot of credit for strength and courage and bravery.”
However, just as many participants (n = 10) had examples of how patients could handle
their at-risk status poorly, such as with destructive behaviors or by ignoring the
possibility of a positive result. Participant #16 summarized it as:
Oh, I think it's really, really hard. I mean everybody that I talk to about it,
no one's ever said to me, ‘Oh, it's okay. It's what it is, you know, it's fine.
It's easy.’ Everyone tells you it's hard.
Even more of the majority of participants (n = 11) spoke of or implied that their patients
were subject to a spectrum of emotions and that the way patients handle risk is as
individualized as they are. As Participant #1 stated, “I think it's as personalized as they
are. I mean, I can see 100 people and there'll be 100 stories.”
An interesting conclusion several counselors made about their HDBD patients
was that they are a self-selected subpopulation. For example, Participant #4 presented the
idea that “Patients who come in for presymptomatic testing are a self-selected group; they
tend to cope well with result (positive or negative) because it is the uncertainty that they
have the hardest time coping with.” The patients that present for genetic counseling

5

Some answers to this question were shared with the next question regarding coping mechanisms. In such
cases, quotes were analyzed interchangeably between the two questions.
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believe that their uncertainty about their at-risk status is worse than knowing their genetic
answer, positive or negative. In fact, we know relatively little about those who are at risk
and are not receiving genetic counseling. Participant #7 put it this way:
I mean, we're only seeing probably the tip of the iceberg of the people who
are at risk and considering the testing. And I think a lot of people are
getting testing in the community and getting very little counseling with it.
And I don't think we have an idea of the consequences because we're not
seeing those people.
Participant #13 made a valid point when she said, “I think the ones who aren't coping
well or don't really want to know never show up. So I think on the whole, genetic
counselors may not really know how people are dealing with their at-risk status.” Indeed,
the perception of genetic counselors may not adequately reflect how all individuals in this
patient population feel about their at-risk status, especially those who refrain from genetic
testing.
2.4.9 What are the different methods you have seen your patients use to cope
during genetic counseling and genetic testing? Perhaps the better question would have
been, “What coping methods have you NOT seen your patients use?” Dozens of coping
methods with different layers of complexity were mentioned, and a number of
participants spoke of how any and every coping method could be seen. As Participant #3
put it, “It's sort of a whole spectrum of different coping mechanisms. Pretty much, if the
coping mechanism exists and it's documented in our textbooks, I've probably seen it.”
Among the more common coping mechanisms were talking to friends and family,
using humor, using spirituality and/or prayer, being angry, seeking all knowledge that
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could be found on their HDBD, denial, getting professional counseling, crying, and
finding support groups. Though many of the coping mechanisms could be helpful, several
could be destructive such as substance abuse or domestic violence.
2.4.10 Please describe your perception of these patients’ stress levels before
the counseling session has begun and after the counseling session. Please describe
your perception of your patients’ stress levels post-session. Questions 10 and 11 both
asked the participants to describe their perceptions of the patients’ stress levels before the
first session, after the first session, and during follow-up. Some overlap of answers
existed with question #9 as well.6 When the answers to these combined questions were
analyzed, three main themes emerged: when are patients stressed, why are patients
stressed, and how can stress be reduced?
When are patients stressed? Every participant perceived that patients come into
their first genetic counseling session with more stress or are more upset coming into a
session than when they leave. Participant #14 provides an example of this sentiment:
I think my perception is that most people come in at a higher stress level at
the beginning or prior to the session than after. We tend to try to gauge our
session around trying to help alleviate some of that stress to the extent you
can… certainly gear it towards what the patient needs to make them feel
comfortable, and I'd rather not send a patient out the door knowing that
their stress level just went up after a session … but overall, I'd like to think
that stress level is at a more manageable level by the end of the session
than prior to the beginning of a counseling session.
6

By mistake, Participant #5 was not asked to describe her perception of her patients’ stress levels postsession.
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From there, the perception of stress level varies. Some spoke of high levels of stress
leading up to the session, during the first session, during the neurological exam, or at the
blood draw. Others spoke of stress levels peaking while waiting for the results or during
the results session. Many participants (n = 7) believed that stress levels decreased during
follow-up, and some of these participants believed that stress levels continued to decrease
over time.
Why are patients stressed? Some participants voiced that it depends on the
patients themselves. Some patients are strong, others calm, others angry, others nervous,
and some stay stressed throughout all their appointments. There could be a whole slew of
variables within the patients’ lives that contribute to how they deal with their genetic
information, as Participant #1elaborated:
I am not a believer in one-size-fits-all. I am absolutely not. I think that
every family I see, I start with a clean slate because people are always
surprising me. People are incredibly unique in their needs, their style, their
background, their history, the burden of what they're facing. One size does
not fit all, absolutely.
Participants had more explanations for why patients may be stressed. Patients may be
stressed because of the complications surrounding the testing protocol. They may not
know what to expect. They may previously have had little contact with medical care.
They may be worried about finances. One participant even said they may be stressed
because they are worried that their stress may disqualify themselves from testing.
The information the results provide can also help explain why patients are
stressed. Several participants noted that negative test results generally come with an
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immediate drop in stress level. In direct contrast, several participants noted that positive
results are inherently stressful. There may be a state of shock after receiving positive
results. Positive results could incite patients to envision themselves declining like an
affected relative. Positive results can lead to SSB. Positive results can also be so stressful
that they call for professional counseling.
How can stress be reduced? Many participants paired their perceptions about
stress levels with thoughts about how to help alleviate stress. Participants may help
reduce stress levels by eliminating the fear of the unknown by answering questions, by
correcting misconceptions, and by familiarizing the patient with the testing protocol.
Participants also spoke of ways to reduce stress by helping patients be able to plan their
testing protocol or plan what their life could look like after testing. Four participants
noted that some patients can have their stress reduced just by knowing that they are not in
this alone; that there is a support system that they can plug into and rely upon. Overall,
there seemed to be a consensus that genetic counselors, in fact, help reduce stress by
fulfilling supportive roles in the medical management of genetic testing.
2.4.11 Do you follow-up with your patients? Perhaps the clearest theme from
this question is that there is no obvious theme. Most participants engaged in some sort of
follow-up with their patients, and this was most often done by phone calls. However,
details such as how often to follow-up, whether or not to follow-up with patients with
negative results, and when to stop pursuing follow-up were varied across the participants.
Even the decision to follow a formal protocol was varied.
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If follow-up was not pursued, it seemed to emanate from the participant’s belief
that the patient did not want to be reminded of their positive test result. When Participant
#5 was asked if she followed-up with her patients, she described this example:
Not usually, no. I did for a while, and then it just didn't seem like patients
wanted that. So I'd say… "Do you want me to give you a call in a couple
weeks and see?" And they'll say, "No, I'll call you if I want to."
Though most participants did pursue follow-up, several of these participants seemed
unsure of what level of follow-up was necessary or wanted by the patients.
2.4.12 How often do patients assign symptoms of a HDBD when their
symptoms may also be indicative of another disorder? Most of the participants, but
not all, have recognized SSB during presymptomatic HDBD testing, and several of these
participants had ideas of who is at greater risk for SSB. When this interview question was
asked, the primary author always paired it with the following example. The participant
was told of a situation in which their patient, who has a family history of EOAD, begins
to have symptoms of memory loss and thus diagnoses herself with EOAD. However, the
memory loss appears to be more indicative of depression. The participants are then asked
to describe how often this type of SSB occurs in their practices.
Out of the 16 participants, 13 believed that this type of SSB does occur. Estimates
of how often range from “almost always” (P#14) to “rare” (P#8) and everything in
between. Two of these 13 participants believed that SSB happens roughly less than half
the time, and another three of these participants are unsure of how often SSB occurs. The
other eight of these participants believed it happens with a greater degree of frequency.
When asked how often she sees SSB for HDBD patients, Participant #2 said:
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I would say a lot. I mean, I think that's just human nature and that makes
sense. If you have this condition that plagues your family, of course you're
going to think every time you forget your keys or, you know, forget where
you put your keys that, "Oh, this could be it!" Or the Huntington's patients,
every time they might trip and fall, they think, "Was that really just...did I
just trip or was that just pure clumsiness and this is related to the
Huntington's." So yeah, a lot! I think that's completely normal.
Participants also had answers as to who is susceptible to SSB. Some examples of
to whom SSB occurs include those who struggle with alcoholism, those who are
asymptomatic, those who are symptomatic, and those with a family history of mental
illness, anxiety, stress, and/or dysfunction. Two participants believe that SSB motivates
people to come in for testing. Two participants stated that parents can have SSB for their
children with other symptoms. Participant #9 stated that patients with positive results are
even more susceptible to SSB:
But then after we disclose people, they have their HD when they test
positive, they have their HD radar on and so they think everything is
Huntington's disease! You know, and it could be the flu and they think it's
somehow Huntington's disease.
However patients display it, these 13 participants believe that SSB is present during
HDBD sessions.
Three participants disagreed that SSB occurs in this kind of presymptomatic
testing scenario. Participant #15 did not recognize any such cases in her practice.
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Participants #5 and #10 found that the opposite was true, that patients are in denial about
symptoms. Participant #5 described it this way:
I've actually found the opposite to be true. I find that when people come in
and I'm thinking, "Oh my goodness, you're symptomatic! Like you're not
pre-symptomatic, you're symptomatic." I think that some people will say,
"No, no! I'm not! Like I think I'm just a stressful person," or, "You know,
I've got a lot going on so I think that my depression is due to, like, all of
these other things. I don't think that I'm symptomatic for HD." You know,
I think that people try to hold onto the hope and to not like, deny that what
they're experiencing is symptoms, sometimes, to protect themselves.
2.4.13 What has been the most rewarding aspect of your work with patients
at risk for HDBDs? Participants found that helping their patients and connecting with
families and communities to be the most rewarding aspects of their work with this patient
population among other aspects. For 14 of the participants, the most rewarding aspect of
working with patients at risk for HDBDs is the opportunity to help patients and/or their
families. Participant #16 explained it this way:
I mean just in general, it's just helping people through, you know, a
difficult time… And so to contribute, like, in a way where you're feeling
like you're doing the best that you can do to help people get the
information that they want and to help guide them through that process is
very rewarding.
Participants also stated that they enjoyed being a resource to patients, identifying
the family disease, helping people cope with the information, hearing gratitude
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and positive feedback from patients, helping with family planning, empowering
and supporting patients, and providing opportunities in research. Three
participants specifically mentioned that giving good news, which is negative
results, to patients is very rewarding. Participant #8 summarized this and the main
theme when she answered:
Gosh, being able to tell someone that they're not going to have this
horrible disease that has devastated their family is wonderful. It's an
absolutely fantastic feeling and I get lots of hugs for it (laughter). But I
think either way it's rewarding because I get to help these people at a
crossroads in their lives and I find that rewarding.
The second most common theme was the reward of connecting with patients, their
families, and their communities (n = 5). Participant #13 captured these sentiments with
her answer:
I think the most rewarding thing has been really being able to know whole
families and being help them in a sense... I really believe that people cope
better when they have good information and good support. And so I think
being in a position to provide that because of my dual role, both in the
program as well as through the support group and through a larger HD
community, has been really rewarding.
Participant #1 also expounded on this point:
And so I think the most rewarding moments I have are when a family
connects well with me. They are grateful for my presence and I know that
in some way I have given them, whether it's support or validation or just
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enough of my, you know, ability to help them cope with the situation at
hand, to tolerate what's going on, those moments that I realize that perhaps
I've been able to do that for them, that's rewarding.
Other rewarding aspects mentioned by participants included the opportunity to
use counseling skills extensively and working as a team with other medical
professionals. In all of these ways, the participants found something to cherish in
their work with HDBD patients.
2.4.14 What has been the most challenging aspect of your work with patients
at risk for HDBDs? In addition to several other themes about the difficulties associated
with HDBD counseling, the most common theme, which half of the participants voiced,
was that giving bad news was the most challenging part of their job. Sometimes, giving
bad news was difficult because there is little or no treatment to offer. Participant #9
voiced this sentiment when she said:
The most challenging aspect is that I don't have anything in my bag of
tricks that really is going to make them feel better. You know, I don't have
any effective treatment or cure, and so I still feel somewhat powerless, you
know, in that aspect of the relationship.
Other times, it was difficult because the news was for presymptomatic individuals.
Participant #6 was struck by both the lack of treatment and the presymptomatic nature of
the results:
The most challenging, I think, is always... is having to tell people that they
are a carrier, that they do have the genetic change. It's difficult information
to tell people. It's hard to be the bearer of that news, you know, bad news.
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And one of the reasons it is so challenging is, at this point, you know, let
alone the fact that they now know they do have the gene and will most
likely develop the disease as long as they live old enough, we don't have
any preventative options. There's nothing that I can tell them that they can
do to reduce their risk in any way.
The reason giving bad news was challenging was sometimes less about the
information itself and more about how to give the information. Participant #5 again noted
that results should be given over the phone because positive results cause patients to
“shut down” and further counseling ceases to benefit patients that day. Participant #14
specifically noted it is difficult to give bad news and the appropriate counseling to
patients who have had testing ordered through physicians who do not follow
presymptomatic testing protocol:
And then the negative impacts that that can have on patients has been very
challenging because ultimately then, what I have seen many individuals
that do come back to us for counseling and it's very difficult. You can't
undo the damage that was done.
Some other challenging aspects of working with patients at risk for HDBDs
included the emotional burden on a counselor (n = 3), the nature of the patient population
(n = 3), having conflicts with patients (n = 2), losing contact with the patients (n = 2), and
other non-counseling aspects of the job (n = 4). The emotional burden to the counselor
could include watching a patient decline in health and independence, witnessing juvenile
onset of the disease, or trying not to take the harder cases “home with you” (P#8). The
HDBD patient population itself could create challenges. Participant #11 commented that
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some of these patients could be “unpredictable,” “intimidating,” and have, “a lot of
emotional issues.” Participant #16 thought some patients were, “really paranoid,” and
Participant #15 thought some patients were not, “necessarily as grateful.” Challenges
such as defending the need for a testing protocol to patients or being subjected to verbal
abuse were mentioned. Two participants noted how patients would be lost to follow-up.
Four participants commented that non-counseling aspects, such as administrative work,
organizing a clinic with patients who are losing executive functioning, or having few
resources available for patients are among the most challenging aspects of working with
this patient population. These were some of the more common challenging aspects of
working with at-risk HDBD patients with giving bad news being the most prevalent.
2.4.15 What advice would you give to a genetic counselor beginning to work
in this field? Though it had been assumed that advice among the participants would be
similar, every participant had an original idea. Nonetheless, themes emerged. Participants
had advice about counseling (n = 9), about getting experience (n = 6), about preparing for
sessions (n = 3), and about working with a team (n = 3) as well as thoughts about the
field of HDBD counseling itself (n = 4).
The most common advice was about how to counsel this patient population. Four
participants emphasized the importance of listening to patients. Participant #9 said to,
“really listen to the stories of the families… you will learn more about HD from these
family stories than you will from any book or any symposium or any article.” More than
knowledge, listening will enable counselors to engage with your patients, as Participant
#1 implores counselors to:
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…not think so much about what you're going to say, but think much more
about what is being said. Listen; LISTEN to your families because they're
going to tell you what they need. Listen; and they're going to tell you their
story. So be patient, be mindful, and be present, and listen carefully.
Other counseling advice included treating every patient as an individual, being
flexible in counseling methods, never assuming anything about patients, and the
importance of finding the balance between being empathic and not “taking the
session home.”
The second most common piece of advice regarded getting experience.
Counselors beginning to work with this patient population should get prior
experience in job shadowing, in clinical exposure, in supervision, in participating
with the affected community, and in getting life experience with affected
individuals. This theme tied in with another theme: working with a team.
Recommendations included getting a mentor, accepting help from other medical
professionals, and creating coalitions of medical professionals with whom to
share cases.
Some advice regarded preparing for sessions. This included creating a
protocol to standardize practice with all patients and reading medical literature to
prepare for any issue that could come up during the session. One participant
specifically advised discussing possible insurance and discrimination issues
surrounding presymptomatic testing with patients during a pre-visit phone call.
Other advice described the field of HDBD counseling itself. Participant #3
had this to say: “Keep in mind it's going to be hard, that it's challenging but it's
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promising, that with HDBDs, there's a lot of research going on.” Participant #15
had more sobering words for counselors considering this field:
I think they should think about it carefully and try to attend a couple
clinics and sit in and watch before they buy into it and sign themselves up
to get involved because I've seen senior genetic counselors who do cancer
genetic counseling, excellent genetic counselors, unable to manage. So it's
not for everyone, you know. There's a niche for everybody, clearly, but I
don't think this area's for everyone.
Participant #7, however, encouraged more counselors to get involved:
Don't be afraid of it… it's really rewarding aspect of genetic counseling
and you can be an expert in this area like no one else can. You're really
some of the best professions prepared to do this kind of work. So get out
there and do it!
The collective advice of all the participants offers invaluable resources and tips to
assist counselors that indeed wish to counsel patients at risk for HDBDs.
2.5 Discussion
As had been previously stated, there are relatively few genetic counselors who
counsel patients at risk for HDBDs. Out of the over 2,850 NSGC members,
approximately 1.5% specialize in neurogenetics (Finucane, 2012; NSGC, 2012). In the
end, only 16 genetic counselors replied to our request for interviews, eight of whom
identified their primary specialty as neurogenetics, thus approximately 19% of the
estimated neurogenetics counselors participated in this study. Though these interviews
were rich in content, there were too few participants to explore possible statistical
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significance by quantitative analysis. For this reason, comparison of themes to
demographics such as practice specialty, length of practice, participation in a HDBD
interdisciplinary clinical team, and use of standard measures was excluded from this
discussion.
We hypothesized that genetic counselors who serve this population would report
using specific agendas in working with patients at risk for HDBDs. As had been
expected, the participants utilized agendas and/or protocols in preparing for and directing
sessions. There was no apparent difference in many of the ways participants prepared for
HDBD sessions when compared to case preparation for any other indication for genetic
counseling such as described by Uhlmann (2009). However, one difference may be that
half of the participants call their at-risk HDBD patients ahead of time, a potentially timeconsuming preparation that may not be seen as often in other practice specialties based on
the experience of the primary author. All but two participants stated their use of some
form of check list, protocol, or agenda to structure their HDBD sessions, and it seemed as
though the agendas were used as a means to meet the needs of the patients.
The specific agendas were unique for each participant rather than being exact
copies of the guidelines for the molecular genetics predictive test in Huntington’s disease
(IHA & WFN, 1994). Guimarães et al. (2013) suggested that counselees receiving
presymptomatic testing for late-onset neurodegenerative disorders desire more flexibility
in protocol to match their expectations and psychological needs. A majority of
participants already claimed to do this by allowing their patients to lead or co-lead the
session and help establish the agenda for the session.
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Though all participants routinely give results to patients at a result disclosure
session, the protocol exceptions for calling out results and/or the amount of follow-up
pursued varied widely. Also, there was no consensus on protocol for how to deal with the
patients’ desire to be tested and the conflicting desires not to know among at-risk family
members. A majority of participants (n = 13) stated that, in the end, they would pursue
presymptomatic testing for their original patient if no compromise could be made.
Despite these differences, it was a common theme to utilize agenda and protocols to
assist in preparing for and directing sessions with patients at-risk for HDBDs.
There is not enough evidence from this study to determine if genetic counselors
who see patients at-risk for HDBDs are at a significant risk for compassion fatigue.
However, certain themes indicate that the risk for compassion fatigue is present for these
genetic counselors and that they have found ways to reduce the risk, such as by talking to
friends and colleagues, engaging in activities outside of work, and mentally and
emotionally preparing for and enduring through sessions. The main theme that indicates
an increased risk for compassion fatigue is the repeated exposure to distressing clinical
events as described by Udipi et al. (2008).
Seven intrapersonal and situational characteristics were identified by Udipi et al.
(2008) to be predictors of compassion fatigue, including: burnout, self-criticism and
giving up, increased number of distressing events, increased patient load, using religion
to cope, having no children, and seeking support to cope. The variable of seeking support
was minimized given the fact that participants of this interview study were asked who
they talked to when they “took sessions home with them.” Out of the remaining six
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variables, the increased number of distressing events seemed most relevant to the
participants of this interview study.
Participants of this study were affected by the distressing events that were among
the most prevalent in the Udipi et al. (2008) study, including giving bad news (i.e.
positive genetic test results), feeling helpless to assist patients, feeling invested
emotionally in the patients’ well-being, and feeling burdened by the knowledge of
positive test results. Giving bad news, the most common distressing event from the Udipi
et al. (2008) study, was listed as the most challenging aspect of working with patients at
risk for HDBDs by half of the participants. Some of the reasons cited for why giving bad
news was so difficult included having no treatment to offer, no hope to give, and the
feeling of taking away the patients’ future with positive results. When participants
answered how giving HDBD results differed from giving other genetic test results,
similar themes emerged, such as lack of treatment and the intensity of results disclosure,
that appear to correlate with the distressing event of feeling helpless to assist patients.
In contrast, connecting with patients, their families, and their communities was
the second most common rewarding aspect of working with patients at risk for HDBDs.
Feeling invested emotionally in the patients’ well-being may become a distressing event
for these genetic counselors if they overextend empathic reserves into their patients.
However, counselees of late-onset neurodegenerative disorders have expressed the need
for empathic engagement from their genetic counselors (Guimarães et al., 2013), and
many participants echoed the importance of connecting with the patient. Lastly, feeling
burdened by the knowledge of positive test results was not a common theme in and of
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itself, though one participant admitted that she would not look at test results until just
before the disclosure session so as to avoid dwelling on the knowledge of the test results.
The increased risk for compassion fatigue based on triggers such as delivering bad
news and consequently feeling responsible for patient suffering are supported by a
previous study by Benoit et al. (2007). However, the increased risk for compassion
fatigue described by Udipi et al. (2008) is caused by a combination of the seven predictor
variables, not just exposure to distressing events. More so, there is no reason to think that
these distressing events are isolated to HDBD counseling. Therefore, this current
interview study does not have enough data to verify an actual increased risk for
compassion fatigue for genetic counselors who see patients at risk for HDBDs. Though
we were not able to measure compassion fatigue using a structured questionnaire,
participants were able to recognize the potential for a problem and they have found ways
to cope with the stress of counseling.
Do genetic counselors perceive their patients as being unable to cope with the
information presented during a genetic counseling session, namely presymptomatic
testing results? This study suggests the opposite, that this patient population is capable of
coping with their own genetic information. When asked to describe their perception of
how patients handled their at-risk status, the most common theme among the participants
was that the patients’ ability to handle risk is as individualized as they are. An equal
number of participants thought that patients handle their risk status well or poorly.
Interestingly, several participants noted that the patients that come to clinic are a selfselected population that cope well with knowledge but not well with uncertainty. Neither
was there a common theme of the coping methods used by this patient population.
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Rather, the examples were a spectrum of different, yet common coping methods used by
the patients; such as talking to friends and family, using humor, using spirituality and/or
prayer, being angry, seeking all knowledge that could be found on their HDBD, and
denial.
Though many participants stated that HDBD test results were intense in nature
and that the stress surrounding presymptomatic testing was high, this in and of itself did
not imply that patients would be unable to cope with the results. In fact, many
participants gave examples of how they could help reduce the stress levels of patients
during the sessions and during follow-up. It is unlikely that so many participants would
try to reduce their patients’ stress levels if they perceived their patients as being unable to
cope anyway. Additionally at many testing centers, the patients who are perceived to be
able to cope would be allowed to interact with the genetic counselors rather than being
referred to therapy and deferred from testing.
Interestingly, all participants believed that patients leave their initial genetic
counseling session less stressed than when they came in. This seems to imply that the atrisk HDBD patient population is capable of coping; indeed, patients can cope right before
the genetic counselors’ eyes. This line of thinking seems to agree with the REVEAL
study which demonstrated that even positive results for AD can be “well tolerated” by
patients who have received genetic counseling (Arribas-Ayllon, 2011). Another
explanation could be that genetic counselors want to believe that they are helping
patients. Therefore, perceived reduction of stress could be a desired perception by genetic
counselors. Whatever the explanation, there was less of a consensus on the ability to cope
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during follow-up, but many participants believed that stress levels decreased over time
thus implying the ability to cope eventually.
One could argue that SSB, by definition, is the inability to cope with uncertainty.
Thirteen of the participants reported SSB in this patient population, but there is no clear
answer on how often this occurs. Therefore, it is unclear whether this patient population
is less able to cope because of their SSB.
Though some of the patient population was sometimes labeled as unpredictable,
highly emotional, and/or more paranoid, these attributes do not confer the inability to
cope with information. Even so, these thoughts were expressed by a minority of
participants. Considering all of the interviews, it does not appear that genetic counselors
by default assume their at-risk HDBD patients are unable to cope with the information
presented during genetic counseling sessions.
The limitations of this study include the total number of interviews and the
potential for the omission of themes. As discussed earlier, there were not enough
participants for quantitative analysis to hold statistical significance. Larger study groups
could help answer some of the questions raised by this study, particularly the effects of
practice specialty, length of practice, participation in a HDBD interdisciplinary clinical
team, and use of standard measures on counseling methods and interpretations. Given the
semi-structured nature of the interviews, genetic counselors may have given implications
by omission. Without asking each counselor specifically about each theme discussed, it is
unclear how many may identify with or disagree with any given theme.
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2.6 Conclusions
We hypothesized that genetic counselors who serve patients at risk for hereditary
degenerative brain disorders (1) utilize agendas/protocols in preparing and directing
sessions, (2) are at a significant risk for compassion fatigue, and (3) perceive their
patients as being unable to cope with the information presented during genetic counseling
sessions. Our study demonstrated that genetic counselors who see patients at risk for
HDBDs utilize agendas and/or protocols in preparing for and directing sessions, though
there were differences among participants in how these were used. Contrary to our
hypothesis, genetic counselors perceive their HDBD patients as capable of coping with
their own presymptomatic testing results. The most common theme of the participants’
risk perception was that the patients’ ability to handle risk is as individualized as they are.
Both the ability to cope and the coping methods used were on a wide, variable spectrum.
Lastly, there was not enough evidence from this study to determine if genetic
counselors who see patients at risk for HDBDs are at any greater risk for compassion
fatigue than other genetic counselors. However, certain themes such as exposure to
distressing events and feeling invested emotionally in the patients’ well-being indicate
that the risk for compassion fatigue is present for these genetic counselors. Nonetheless,
these participants have found ways to reduce the risk, such as by talking to friends and
colleagues, engaging in activities outside of work, and both mentally and emotionally
preparing for and enduring through sessions. Additionally, the participants listed positive
feelings experienced by counseling these patients that balance the negative feelings
surrounding the job.
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Overall, the genetic counselors who see patients at risk for HDBDs are more
similar to than different from genetic counselors who do not see this patient population.
Genetic counselors who may wish to serve this patient population will have most of the
necessary skills to succeed in providing the best care for presymptomatic testing and
follow-up. Several participants in this study gave advice to incoming genetic counselors
to seek experience with the HDBD community and medical expertise before counseling
this patient population. The addition of HDBD case observation and HDBD patient
counseling to the curriculum of any board-certified Genetic Counseling program has the
potential to greatly assist new counselors in gaining this type of experience. Given that a
significant number of people are living at risk for adult-onset neurodegenerative
disorders, these learning experiences could benefit genetic counselors and the patients
they serve.
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Chapter 3: Conclusions
We hypothesized that genetic counselors who serve patients at risk for hereditary
degenerative brain disorders (1) utilize agendas/protocols in preparing and directing
sessions, (2) are at a significant risk for compassion fatigue, and (3) perceive their
patients as being unable to cope with the information presented during genetic counseling
sessions. Our study demonstrated that genetic counselors who see patients at risk for
HDBDs utilize agendas and/or protocols in preparing for and directing sessions, though
there were differences among participants in how these were used. Contrary to our
hypothesis, genetic counselors perceive their HDBD patients as capable of coping with
their own presymptomatic testing results. The most common theme of the participants’
risk perception was that the patients’ ability to handle risk is as individualized as they are.
Both the ability to cope and the coping methods used were on a wide, variable spectrum.
Lastly, there was not enough evidence from this study to determine if genetic
counselors who see patients at risk for HDBDs are at any greater risk for compassion
fatigue than other genetic counselors. However, certain themes such as exposure to
distressing events and feeling invested emotionally in the patients’ well-being indicate
that the risk for compassion fatigue is present for these genetic counselors. Nonetheless,
these participants have found ways to reduce the risk, such as by talking to friends and
colleagues, engaging in activities outside of work, and both mentally and emotionally
preparing for and enduring through sessions. Additionally, the participants listed positive
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feelings experienced by counseling these patients that balance the negative feelings
surrounding the job.
Overall, the genetic counselors who see patients at risk for HDBDs are more
similar to than different from genetic counselors who do not see this patient population.
Genetic counselors who may wish to serve this patient population will have most of the
necessary skills to succeed in providing the best care for presymptomatic testing and
follow-up. Several participants in this study gave advice to incoming genetic counselors
to seek experience with the HDBD community and medical expertise before counseling
this patient population. The addition of HDBD case observation and HDBD patient
counseling to the curriculum of any board-certified Genetic Counseling program has the
potential to greatly assist new counselors in gaining this type of experience. Given that a
significant number of people are living at risk for adult-onset neurodegenerative
disorders, these learning experiences could benefit genetic counselors and the patients
they serve.
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Appendix
Interview Questions
The following list of questions was used as an outline for the interview questions. Where
appropriate, the interviewees were asked to expand upon their answers.
QUANTITATIVE QUESTIONS
1.

2.

What is your practice specialty?
a.

Prenatal

b.

Pediatric

c.

Cancer

d.

General genetics

e.

Assisted reproduction

f.

Research

g.

Laboratory

h.

Neurogenetics

i.

Other

How long have you been a practicing genetic counselor?
a.

0-5 years

b.

6-10 years

c.

11-15 years

d.

15-20 years

e.

20 or more year
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3.

What percentage of your total caseload is spent with patients at-risk for a
hereditary degenerative brain disorders (HDBD) versus other patients (e.g.
pediatric, cancer, etc.)?

4.

a.

Less than 25% with HDBD patients

b.

26%-50% with HDBD patients

c.

51%-75% with HDBD patients

d.

More than 75% with HDBD patients

Are you part of a hereditary degenerative brain disorders interdisciplinary clinical
team?

5.

a.

Yes

b.

No

Do you routinely see patients at-risk for a hereditary degenerative brain disorder
or with a hereditary brain disorder for continuing evaluation and/or treatment?

6.

7.

a.

Yes

b.

No

Do you evaluate patients’ stress levels with a structured questionnaire?
a.

Yes

b.

No

Do you or your clinic use standard measures for anxiety and/or depression with
patients at-risk for a hereditary degenerative brain disorder?
a.

Yes

b.

No
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QUALITATIVE QUESTIONS
1. What do you do to prepare for a session with an individual at-risk for a HDBD?
2. How do you direct a session with an individual at-risk for a HDBD?
3. How do you handle the patient's needs versus the patient's family's needs?
4. How do you give results for genetic testing, positive and negative? How does
giving results for a HDBD differ from giving other genetic tests results, if at all?
5. Do you prepare yourself emotionally for a session with an individual at-risk for a
HDBD?
6. How do you handle emotions during the session, both that of yours and your
patient’s?
7. What do you do if you cannot keep from “taking the session home” with you?
Who do you talk to?
8. How do you believe your patients handle being at-risk for a HDBD?
9. What are the different methods you have seen your patients use to cope during
genetic counseling and genetic testing?
10. Please describe your perception of these patients’ stress levels before the
counseling session has begun and after the counseling session.
11. Do you follow-up with your patients? If so, how? Please describe your perception
of your patients’ stress levels post-session.
12. How often do patients assign symptoms of HDBD when their symptoms may also
be indicative of another disorder?
13. What has been the most rewarding aspect of your work with patients at-risk for
HDBD?
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14. What has been the most challenging aspect of your work with patients at-risk for
HDBD?
15. What advice would you give to a genetic counselor beginning to work in this
field?

68

